Facebook tracking pixel
S10.AI
ICD-10-CM · Z86.42GeneralSystemic

History of Polysubstance Abuse

Find information on documenting and coding a history of polysubstance abuse in healthcare settings. Learn about clinical documentation improvement, ICD-10 codes for polysubstance dependence and abuse, DSM-5 criteria, substance use disorder treatment, and best practices for accurate medical coding related to a past history of drug abuse and alcohol abuse. This resource provides guidance for clinicians, medical coders, and healthcare professionals on proper terminology and documentation for patients with a history of multiple substance use.

Also known as
Polysubstance Use DisorderMultiple Substance Abuse History
Definition

Repeated use of multiple substances, leading to significant impairment or distress.

Clinical signs

Intoxication, withdrawal symptoms, cravings, changes in mood or behavior, neglecting responsibilities.

Common settings

Detoxification centers, inpatient rehab programs, outpatient counseling, support groups.

Related Codes

ICD-10 Code Families

Complete code families applicable to Z86.42

F19
Mental/behavioral dis. due to mult. drug use
Z86.4
Personal history of psychoactive substance abuse
F10-F19
Mental/behavioral dis. due to psychoactive substance use
Code Comparison

When to use each related code

DescriptionWhen to use
Polysubstance abuseConcurrent abuse of multiple substances. Excludes nicotine and caffeine. Code primary substance if known.
Opioid use disorderProblematic opioid use with impaired control, social issues, risky use, and tolerance/withdrawal. Specify severity.
Stimulant use disorderProblematic stimulant use (e.g., cocaine, amphetamines) causing impairment. Specify severity.
Documentation

Best-practice checklist

  • ✓Specific substances used, route, frequency, amount.
  • ✓Dates of first and last use for each substance.
  • ✓Prior treatment history and outcomes if any.
  • ✓Current withdrawal symptoms or complications.
  • ✓Impact of substance use on social/occupational functioning.
Coding & Audit Risks

Common pitfalls to avoid

Unspecified Substances

Coding F19.20 requires specific substance documentation. Lack of detail leads to coding errors and claim denials.

Active vs. History

Distinguishing active abuse (F19.20) from history (F19.25) is crucial. Incorrect coding impacts severity and reimbursement.

Comorbid Conditions

Polysubstance abuse often coexists with mental health disorders. Incomplete documentation can lead to missed CC/MCC capture.

Mitigation

Best-practice tips

  • 01Document specific substances, frequency, & route for accurate ICD-10-CM coding (F19.-)
  • 02CDI: Query for substance use onset, cessation dates, & treatment history for HCC capture
  • 03Ensure medical necessity for polysubstance abuse treatment aligns with payer guidelines
  • 04Screen for co-occurring mental health disorders for comprehensive care & coding (dual diagnosis)
  • 05Monitor patient for relapse & document interventions for improved outcomes & compliance
Clinical Decision Support

Step-by-step checklist

  1. 1

    Verify documentation of two or more substance use disorders within a 12-month period ICD-10 F19.20

  2. 2

    Confirm patient history details types of substances, frequency, and duration of use

  3. 3

    Screen for co-occurring mental health disorders DSM-5 dual diagnosis improve patient safety

  4. 4

    Assess for withdrawal symptoms and provide appropriate management to ensure patient safety

  5. 5

    Document treatment plan including referrals to addiction specialist for optimal care coordination

Documentation Template

Ready-to-paste narrative

Patient presents with a history of polysubstance abuse, meeting DSM-5 criteria for this diagnosis.  The patient reports a long-term pattern of concurrent or sequential use of multiple substances including alcohol, opioids, and stimulants.  Onset of use began in adolescence, escalating in recent years.  The patient acknowledges significant impairment in social, occupational, and recreational functioning due to substance use, including job loss, strained family relationships, and legal issues related to driving under the influence.  Symptoms include cravings, withdrawal symptoms upon cessation, and continued use despite negative consequences.  Physical examination reveals evidence of past intravenous drug use with track marks present.  Mental status examination reveals anxious mood, psychomotor agitation, and impaired judgment.  Patient denies suicidal or homicidal ideation.  Assessment includes substance use disorder, polysubstance dependence, addiction treatment, and relapse prevention.  Plan includes referral to substance abuse counseling, individual therapy addressing underlying psychological factors contributing to substance use, and consideration for medication-assisted treatment (MAT) options such as naltrexone or buprenorphine.  Patient education provided on risks of continued polysubstance use, harm reduction strategies, and available community resources.  Follow-up appointment scheduled to monitor progress and adjust treatment plan as needed.  Differential diagnosis includes mood disorders, anxiety disorders, and personality disorders.  Prognosis guarded but improves with adherence to treatment recommendations.  ICD-10 code F19.20 will be used for billing purposes.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.